Glossary of Terms

Last updated: 2026-03-27


Overview

This glossary provides definitions for the common terms and acronyms used throughout the ALIGN Global Hub.

Terms and Acronyms

Term / Acronym Definition
ALIGN Advancing Country-Led Innovation Introduction through Government Engagement and EvideNce.
DALY Disability-Adjusted Life Year. A measure of overall disease burden, expressed as the number of years lost due to ill-health, disability, or early death.
EML Essential Medicines List. A list of medicines that satisfy the priority health care needs of a population, maintained by the WHO and national governments.
GBD Global Burden of Disease. A comprehensive regional and global research program of disease burden that assesses mortality and disability from major diseases, injuries, and risk factors.
GRA Global Regulatory Approval. Refers to approval or prequalification by a global body such as the WHO, US FDA, or EMA.
IHME Institute for Health Metrics and Evaluation.
LMIC Low- and Middle-Income Country.
MNCH Maternal, Newborn, and Child Health.
NRA National Regulatory Authority. The government body responsible for regulating health products at the country level.
P2I Portfolio-to-Impact. A model used to estimate development costs, timelines, and probabilities of success for health product portfolios.
WHO PQ World Health Organization Prequalification. A service that ensures health products meet global standards of quality, safety, and efficacy.

Further Reading

For more detailed information on specific fields and data sources, refer to the Data Dictionary and Integrated Horizon Scanning Sources.


© 2026 ALIGN Consortium. All rights reserved.

Website  |  GitHub  |  Contact